nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—esophageal cancer	0.799	1	CbGaD
Pilocarpine—WBC abnormal NOS—Capecitabine—esophageal cancer	0.0048	0.0443	CcSEcCtD
Pilocarpine—White blood cell disorder—Capecitabine—esophageal cancer	0.00402	0.0371	CcSEcCtD
Pilocarpine—Developmental delay—Capecitabine—esophageal cancer	0.00183	0.0169	CcSEcCtD
Pilocarpine—Congenital anomaly—Capecitabine—esophageal cancer	0.00183	0.0169	CcSEcCtD
Pilocarpine—Retinal disorder—Methotrexate—esophageal cancer	0.00145	0.0134	CcSEcCtD
Pilocarpine—Visual acuity reduced—Capecitabine—esophageal cancer	0.00117	0.0108	CcSEcCtD
Pilocarpine—Ageusia—Cisplatin—esophageal cancer	0.00117	0.0108	CcSEcCtD
Pilocarpine—Infection—Carboplatin—esophageal cancer	0.00114	0.0105	CcSEcCtD
Pilocarpine—Neck stiffness—Methotrexate—esophageal cancer	0.00109	0.0101	CcSEcCtD
Pilocarpine—Aphasia—Capecitabine—esophageal cancer	0.00107	0.00991	CcSEcCtD
Pilocarpine—Keratitis—Capecitabine—esophageal cancer	0.00107	0.00991	CcSEcCtD
Pilocarpine—Nuchal rigidity—Methotrexate—esophageal cancer	0.001	0.00923	CcSEcCtD
Pilocarpine—Thrombosis—Capecitabine—esophageal cancer	0.000985	0.00909	CcSEcCtD
Pilocarpine—Pain—Carboplatin—esophageal cancer	0.000983	0.00907	CcSEcCtD
Pilocarpine—Metrorrhagia—Capecitabine—esophageal cancer	0.000976	0.009	CcSEcCtD
Pilocarpine—Laryngitis—Capecitabine—esophageal cancer	0.000967	0.00892	CcSEcCtD
Pilocarpine—Tongue disorder—Capecitabine—esophageal cancer	0.000958	0.00884	CcSEcCtD
Pilocarpine—Hiccups—Cisplatin—esophageal cancer	0.000945	0.00872	CcSEcCtD
Pilocarpine—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.000942	0.00869	CcSEcCtD
Pilocarpine—Body temperature increased—Carboplatin—esophageal cancer	0.000909	0.00839	CcSEcCtD
Pilocarpine—Skin ulcer—Capecitabine—esophageal cancer	0.000895	0.00826	CcSEcCtD
Pilocarpine—Ageusia—Capecitabine—esophageal cancer	0.00086	0.00794	CcSEcCtD
Pilocarpine—Eye irritation—Capecitabine—esophageal cancer	0.000816	0.00753	CcSEcCtD
Pilocarpine—Aphasia—Methotrexate—esophageal cancer	0.0008	0.00738	CcSEcCtD
Pilocarpine—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.000777	0.00717	CcSEcCtD
Pilocarpine—Cyst—Methotrexate—esophageal cancer	0.000776	0.00716	CcSEcCtD
Pilocarpine—Deafness—Cisplatin—esophageal cancer	0.000767	0.00708	CcSEcCtD
Pilocarpine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000766	0.00707	CcSEcCtD
Pilocarpine—Herpes simplex—Capecitabine—esophageal cancer	0.000756	0.00698	CcSEcCtD
Pilocarpine—Lacrimation increased—Capecitabine—esophageal cancer	0.000756	0.00698	CcSEcCtD
Pilocarpine—Cataract—Capecitabine—esophageal cancer	0.000732	0.00676	CcSEcCtD
Pilocarpine—Neck pain—Capecitabine—esophageal cancer	0.000705	0.00651	CcSEcCtD
Pilocarpine—Hiccups—Capecitabine—esophageal cancer	0.000697	0.00643	CcSEcCtD
Pilocarpine—Melaena—Capecitabine—esophageal cancer	0.000681	0.00628	CcSEcCtD
Pilocarpine—Urinary incontinence—Capecitabine—esophageal cancer	0.000673	0.00621	CcSEcCtD
Pilocarpine—Colitis—Capecitabine—esophageal cancer	0.000669	0.00617	CcSEcCtD
Pilocarpine—Skin ulcer—Methotrexate—esophageal cancer	0.000666	0.00615	CcSEcCtD
Pilocarpine—Candida infection—Capecitabine—esophageal cancer	0.000665	0.00614	CcSEcCtD
Pilocarpine—Face oedema—Cisplatin—esophageal cancer	0.000663	0.00611	CcSEcCtD
Pilocarpine—Gingivitis—Methotrexate—esophageal cancer	0.000661	0.0061	CcSEcCtD
Pilocarpine—Dry eye—Capecitabine—esophageal cancer	0.000644	0.00594	CcSEcCtD
Pilocarpine—Oesophagitis—Capecitabine—esophageal cancer	0.000637	0.00588	CcSEcCtD
Pilocarpine—Abnormal vision—Capecitabine—esophageal cancer	0.000608	0.00561	CcSEcCtD
Pilocarpine—Mental disability—Capecitabine—esophageal cancer	0.000605	0.00558	CcSEcCtD
Pilocarpine—Speech disorder—Methotrexate—esophageal cancer	0.000603	0.00557	CcSEcCtD
Pilocarpine—Ear pain—Capecitabine—esophageal cancer	0.000593	0.00547	CcSEcCtD
Pilocarpine—Pancreatitis—Cisplatin—esophageal cancer	0.000582	0.00537	CcSEcCtD
Pilocarpine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.000578	0.00534	CcSEcCtD
Pilocarpine—Bone disorder—Methotrexate—esophageal cancer	0.000574	0.0053	CcSEcCtD
Pilocarpine—Gastroenteritis—Capecitabine—esophageal cancer	0.000571	0.00527	CcSEcCtD
Pilocarpine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00057	0.00526	CcSEcCtD
Pilocarpine—Deafness—Capecitabine—esophageal cancer	0.000565	0.00522	CcSEcCtD
Pilocarpine—Glossitis—Methotrexate—esophageal cancer	0.000563	0.00519	CcSEcCtD
Pilocarpine—Herpes simplex—Methotrexate—esophageal cancer	0.000563	0.00519	CcSEcCtD
Pilocarpine—Eye pain—Capecitabine—esophageal cancer	0.00056	0.00517	CcSEcCtD
Pilocarpine—Increased appetite—Capecitabine—esophageal cancer	0.000538	0.00497	CcSEcCtD
Pilocarpine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000536	0.00495	CcSEcCtD
Pilocarpine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000529	0.00488	CcSEcCtD
Pilocarpine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000521	0.00481	CcSEcCtD
Pilocarpine—Arthritis—Capecitabine—esophageal cancer	0.00052	0.0048	CcSEcCtD
Pilocarpine—Vaginal inflammation—Methotrexate—esophageal cancer	0.000519	0.00479	CcSEcCtD
Pilocarpine—Myocardial infarction—Cisplatin—esophageal cancer	0.000518	0.00478	CcSEcCtD
Pilocarpine—Stomatitis—Cisplatin—esophageal cancer	0.000515	0.00476	CcSEcCtD
Pilocarpine—Conjunctivitis—Cisplatin—esophageal cancer	0.000514	0.00474	CcSEcCtD
Pilocarpine—Melaena—Methotrexate—esophageal cancer	0.000507	0.00468	CcSEcCtD
Pilocarpine—Migraine—Capecitabine—esophageal cancer	0.000498	0.00459	CcSEcCtD
Pilocarpine—Vaginal infection—Methotrexate—esophageal cancer	0.00049	0.00452	CcSEcCtD
Pilocarpine—Face oedema—Capecitabine—esophageal cancer	0.000488	0.00451	CcSEcCtD
Pilocarpine—Bradycardia—Cisplatin—esophageal cancer	0.000483	0.00446	CcSEcCtD
Pilocarpine—Mood swings—Capecitabine—esophageal cancer	0.000479	0.00442	CcSEcCtD
Pilocarpine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000467	0.00431	CcSEcCtD
Pilocarpine—Dry skin—Capecitabine—esophageal cancer	0.000464	0.00428	CcSEcCtD
Pilocarpine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000462	0.00426	CcSEcCtD
Pilocarpine—Visual impairment—Cisplatin—esophageal cancer	0.000458	0.00422	CcSEcCtD
Pilocarpine—Gastritis—Capecitabine—esophageal cancer	0.000448	0.00413	CcSEcCtD
Pilocarpine—Muscular weakness—Capecitabine—esophageal cancer	0.000446	0.00412	CcSEcCtD
Pilocarpine—Eye disorder—Cisplatin—esophageal cancer	0.000444	0.00409	CcSEcCtD
Pilocarpine—Tinnitus—Cisplatin—esophageal cancer	0.000443	0.00408	CcSEcCtD
Pilocarpine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000441	0.00407	CcSEcCtD
Pilocarpine—Flushing—Cisplatin—esophageal cancer	0.000441	0.00407	CcSEcCtD
Pilocarpine—Influenza—Capecitabine—esophageal cancer	0.000437	0.00403	CcSEcCtD
Pilocarpine—Dysphagia—Capecitabine—esophageal cancer	0.000437	0.00403	CcSEcCtD
Pilocarpine—Bronchospasm—Capecitabine—esophageal cancer	0.00043	0.00397	CcSEcCtD
Pilocarpine—Angina pectoris—Capecitabine—esophageal cancer	0.000426	0.00393	CcSEcCtD
Pilocarpine—Arrhythmia—Cisplatin—esophageal cancer	0.000424	0.00391	CcSEcCtD
Pilocarpine—Bronchitis—Capecitabine—esophageal cancer	0.00042	0.00388	CcSEcCtD
Pilocarpine—Alopecia—Cisplatin—esophageal cancer	0.00042	0.00387	CcSEcCtD
Pilocarpine—Dysuria—Capecitabine—esophageal cancer	0.000409	0.00377	CcSEcCtD
Pilocarpine—Flatulence—Cisplatin—esophageal cancer	0.000407	0.00376	CcSEcCtD
Pilocarpine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000399	0.00368	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000399	0.00368	CcSEcCtD
Pilocarpine—Muscle spasms—Cisplatin—esophageal cancer	0.000397	0.00367	CcSEcCtD
Pilocarpine—Pneumonia—Capecitabine—esophageal cancer	0.000392	0.00362	CcSEcCtD
Pilocarpine—Vision blurred—Cisplatin—esophageal cancer	0.000389	0.00359	CcSEcCtD
Pilocarpine—Tremor—Cisplatin—esophageal cancer	0.000387	0.00357	CcSEcCtD
Pilocarpine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000384	0.00355	CcSEcCtD
Pilocarpine—Myocardial infarction—Capecitabine—esophageal cancer	0.000382	0.00353	CcSEcCtD
Pilocarpine—Stomatitis—Capecitabine—esophageal cancer	0.00038	0.00351	CcSEcCtD
Pilocarpine—Conjunctivitis—Capecitabine—esophageal cancer	0.000379	0.0035	CcSEcCtD
Pilocarpine—Urinary tract infection—Capecitabine—esophageal cancer	0.000379	0.0035	CcSEcCtD
Pilocarpine—Haematuria—Capecitabine—esophageal cancer	0.000372	0.00343	CcSEcCtD
Pilocarpine—Leukopenia—Cisplatin—esophageal cancer	0.00037	0.00341	CcSEcCtD
Pilocarpine—Epistaxis—Capecitabine—esophageal cancer	0.000368	0.00339	CcSEcCtD
Pilocarpine—Mood swings—Methotrexate—esophageal cancer	0.000357	0.00329	CcSEcCtD
Pilocarpine—Bradycardia—Capecitabine—esophageal cancer	0.000356	0.00329	CcSEcCtD
Pilocarpine—Myalgia—Cisplatin—esophageal cancer	0.000352	0.00325	CcSEcCtD
Pilocarpine—Rhinitis—Capecitabine—esophageal cancer	0.000351	0.00324	CcSEcCtD
Pilocarpine—Anxiety—Cisplatin—esophageal cancer	0.000351	0.00324	CcSEcCtD
Pilocarpine—Hepatitis—Capecitabine—esophageal cancer	0.00035	0.00323	CcSEcCtD
Pilocarpine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000348	0.00321	CcSEcCtD
Pilocarpine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000348	0.00321	CcSEcCtD
Pilocarpine—Discomfort—Cisplatin—esophageal cancer	0.000348	0.00321	CcSEcCtD
Pilocarpine—Pharyngitis—Capecitabine—esophageal cancer	0.000347	0.00321	CcSEcCtD
Pilocarpine—Oedema peripheral—Capecitabine—esophageal cancer	0.000345	0.00318	CcSEcCtD
Pilocarpine—Oedema—Cisplatin—esophageal cancer	0.000337	0.00311	CcSEcCtD
Pilocarpine—Visual impairment—Capecitabine—esophageal cancer	0.000337	0.00311	CcSEcCtD
Pilocarpine—Infection—Cisplatin—esophageal cancer	0.000335	0.00309	CcSEcCtD
Pilocarpine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00033	0.00305	CcSEcCtD
Pilocarpine—Tachycardia—Cisplatin—esophageal cancer	0.000329	0.00304	CcSEcCtD
Pilocarpine—Eye disorder—Capecitabine—esophageal cancer	0.000327	0.00302	CcSEcCtD
Pilocarpine—Tinnitus—Capecitabine—esophageal cancer	0.000326	0.00301	CcSEcCtD
Pilocarpine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000326	0.00301	CcSEcCtD
Pilocarpine—Flushing—Capecitabine—esophageal cancer	0.000325	0.003	CcSEcCtD
Pilocarpine—Anorexia—Cisplatin—esophageal cancer	0.000322	0.00297	CcSEcCtD
Pilocarpine—Pancreatitis—Methotrexate—esophageal cancer	0.000319	0.00294	CcSEcCtD
Pilocarpine—Hypotension—Cisplatin—esophageal cancer	0.000315	0.00291	CcSEcCtD
Pilocarpine—Chills—Capecitabine—esophageal cancer	0.000314	0.0029	CcSEcCtD
Pilocarpine—Arrhythmia—Capecitabine—esophageal cancer	0.000313	0.00288	CcSEcCtD
Pilocarpine—Alopecia—Capecitabine—esophageal cancer	0.000309	0.00285	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000307	0.00284	CcSEcCtD
Pilocarpine—Dysuria—Methotrexate—esophageal cancer	0.000304	0.00281	CcSEcCtD
Pilocarpine—Paraesthesia—Cisplatin—esophageal cancer	0.000303	0.00279	CcSEcCtD
Pilocarpine—Dyspnoea—Cisplatin—esophageal cancer	0.000301	0.00277	CcSEcCtD
Pilocarpine—Flatulence—Capecitabine—esophageal cancer	0.0003	0.00277	CcSEcCtD
Pilocarpine—Dysgeusia—Capecitabine—esophageal cancer	0.000298	0.00275	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000297	0.00274	CcSEcCtD
Pilocarpine—Back pain—Capecitabine—esophageal cancer	0.000295	0.00272	CcSEcCtD
Pilocarpine—Decreased appetite—Cisplatin—esophageal cancer	0.000293	0.00271	CcSEcCtD
Pilocarpine—Muscle spasms—Capecitabine—esophageal cancer	0.000293	0.0027	CcSEcCtD
Pilocarpine—Pneumonia—Methotrexate—esophageal cancer	0.000292	0.00269	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000291	0.00269	CcSEcCtD
Pilocarpine—Pain—Cisplatin—esophageal cancer	0.000288	0.00266	CcSEcCtD
Pilocarpine—Vision blurred—Capecitabine—esophageal cancer	0.000287	0.00265	CcSEcCtD
Pilocarpine—Tremor—Capecitabine—esophageal cancer	0.000285	0.00263	CcSEcCtD
Pilocarpine—Stomatitis—Methotrexate—esophageal cancer	0.000283	0.00261	CcSEcCtD
Pilocarpine—Conjunctivitis—Methotrexate—esophageal cancer	0.000282	0.0026	CcSEcCtD
Pilocarpine—Sweating—Methotrexate—esophageal cancer	0.000278	0.00257	CcSEcCtD
Pilocarpine—Feeling abnormal—Cisplatin—esophageal cancer	0.000278	0.00256	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—esophageal cancer	0.000277	0.00255	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—esophageal cancer	0.000274	0.00253	CcSEcCtD
Pilocarpine—Syncope—Capecitabine—esophageal cancer	0.000273	0.00252	CcSEcCtD
Pilocarpine—Leukopenia—Capecitabine—esophageal cancer	0.000273	0.00252	CcSEcCtD
Pilocarpine—Palpitations—Capecitabine—esophageal cancer	0.000269	0.00248	CcSEcCtD
Pilocarpine—Loss of consciousness—Capecitabine—esophageal cancer	0.000268	0.00247	CcSEcCtD
Pilocarpine—Body temperature increased—Cisplatin—esophageal cancer	0.000267	0.00246	CcSEcCtD
Pilocarpine—Cough—Capecitabine—esophageal cancer	0.000266	0.00245	CcSEcCtD
Pilocarpine—Hypertension—Capecitabine—esophageal cancer	0.000263	0.00243	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—esophageal cancer	0.000261	0.0024	CcSEcCtD
Pilocarpine—Myalgia—Capecitabine—esophageal cancer	0.000259	0.00239	CcSEcCtD
Pilocarpine—Arthralgia—Capecitabine—esophageal cancer	0.000259	0.00239	CcSEcCtD
Pilocarpine—Chest pain—Capecitabine—esophageal cancer	0.000259	0.00239	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—esophageal cancer	0.000259	0.00239	CcSEcCtD
Pilocarpine—Anxiety—Capecitabine—esophageal cancer	0.000258	0.00239	CcSEcCtD
Pilocarpine—Discomfort—Capecitabine—esophageal cancer	0.000256	0.00236	CcSEcCtD
Pilocarpine—Visual impairment—Methotrexate—esophageal cancer	0.000251	0.00232	CcSEcCtD
Pilocarpine—Confusional state—Capecitabine—esophageal cancer	0.000251	0.00231	CcSEcCtD
Pilocarpine—Oedema—Capecitabine—esophageal cancer	0.000249	0.00229	CcSEcCtD
Pilocarpine—Hypersensitivity—Cisplatin—esophageal cancer	0.000248	0.00229	CcSEcCtD
Pilocarpine—Infection—Capecitabine—esophageal cancer	0.000247	0.00228	CcSEcCtD
Pilocarpine—Shock—Capecitabine—esophageal cancer	0.000245	0.00226	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—esophageal cancer	0.000243	0.00225	CcSEcCtD
Pilocarpine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000243	0.00225	CcSEcCtD
Pilocarpine—Tinnitus—Methotrexate—esophageal cancer	0.000243	0.00224	CcSEcCtD
Pilocarpine—Tachycardia—Capecitabine—esophageal cancer	0.000243	0.00224	CcSEcCtD
Pilocarpine—Asthenia—Cisplatin—esophageal cancer	0.000242	0.00223	CcSEcCtD
Pilocarpine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00024	0.00222	CcSEcCtD
Pilocarpine—Anorexia—Capecitabine—esophageal cancer	0.000237	0.00219	CcSEcCtD
Pilocarpine—Chills—Methotrexate—esophageal cancer	0.000234	0.00216	CcSEcCtD
Pilocarpine—Hypotension—Capecitabine—esophageal cancer	0.000232	0.00214	CcSEcCtD
Pilocarpine—Diarrhoea—Cisplatin—esophageal cancer	0.000231	0.00213	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—esophageal cancer	0.00023	0.00212	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000227	0.00209	CcSEcCtD
Pilocarpine—Insomnia—Capecitabine—esophageal cancer	0.000225	0.00208	CcSEcCtD
Pilocarpine—Paraesthesia—Capecitabine—esophageal cancer	0.000223	0.00206	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—esophageal cancer	0.000222	0.00205	CcSEcCtD
Pilocarpine—Dyspnoea—Capecitabine—esophageal cancer	0.000222	0.00205	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—esophageal cancer	0.000219	0.00202	CcSEcCtD
Pilocarpine—Dyspepsia—Capecitabine—esophageal cancer	0.000219	0.00202	CcSEcCtD
Pilocarpine—Decreased appetite—Capecitabine—esophageal cancer	0.000216	0.00199	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000215	0.00198	CcSEcCtD
Pilocarpine—Vomiting—Cisplatin—esophageal cancer	0.000214	0.00198	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—esophageal cancer	0.000214	0.00197	CcSEcCtD
Pilocarpine—Rash—Cisplatin—esophageal cancer	0.000213	0.00196	CcSEcCtD
Pilocarpine—Pain—Capecitabine—esophageal cancer	0.000213	0.00196	CcSEcCtD
Pilocarpine—Constipation—Capecitabine—esophageal cancer	0.000213	0.00196	CcSEcCtD
Pilocarpine—Dermatitis—Cisplatin—esophageal cancer	0.000212	0.00196	CcSEcCtD
Pilocarpine—Feeling abnormal—Capecitabine—esophageal cancer	0.000205	0.00189	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000203	0.00188	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—esophageal cancer	0.000203	0.00187	CcSEcCtD
Pilocarpine—Nausea—Cisplatin—esophageal cancer	0.0002	0.00185	CcSEcCtD
Pilocarpine—Cough—Methotrexate—esophageal cancer	0.000198	0.00183	CcSEcCtD
Pilocarpine—Abdominal pain—Capecitabine—esophageal cancer	0.000197	0.00181	CcSEcCtD
Pilocarpine—Body temperature increased—Capecitabine—esophageal cancer	0.000197	0.00181	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—esophageal cancer	0.000193	0.00178	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—esophageal cancer	0.000193	0.00178	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—esophageal cancer	0.000193	0.00178	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—esophageal cancer	0.000191	0.00176	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—esophageal cancer	0.000187	0.00172	CcSEcCtD
Pilocarpine—Infection—Methotrexate—esophageal cancer	0.000184	0.0017	CcSEcCtD
Pilocarpine—Hypersensitivity—Capecitabine—esophageal cancer	0.000183	0.00169	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000181	0.00167	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000179	0.00165	CcSEcCtD
Pilocarpine—Asthenia—Capecitabine—esophageal cancer	0.000178	0.00165	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—esophageal cancer	0.000176	0.00163	CcSEcCtD
Pilocarpine—Pruritus—Capecitabine—esophageal cancer	0.000176	0.00162	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—esophageal cancer	0.000173	0.0016	CcSEcCtD
Pilocarpine—Diarrhoea—Capecitabine—esophageal cancer	0.00017	0.00157	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000169	0.00156	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—esophageal cancer	0.000167	0.00154	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—esophageal cancer	0.000166	0.00153	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—esophageal cancer	0.000165	0.00152	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—esophageal cancer	0.000165	0.00152	CcSEcCtD
Pilocarpine—Dizziness—Capecitabine—esophageal cancer	0.000164	0.00152	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—esophageal cancer	0.000163	0.0015	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—esophageal cancer	0.000161	0.00148	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00016	0.00147	CcSEcCtD
Pilocarpine—Pain—Methotrexate—esophageal cancer	0.000158	0.00146	CcSEcCtD
Pilocarpine—Vomiting—Capecitabine—esophageal cancer	0.000158	0.00146	CcSEcCtD
Pilocarpine—Rash—Capecitabine—esophageal cancer	0.000157	0.00145	CcSEcCtD
Pilocarpine—Dermatitis—Capecitabine—esophageal cancer	0.000157	0.00145	CcSEcCtD
Pilocarpine—Headache—Capecitabine—esophageal cancer	0.000156	0.00144	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—esophageal cancer	0.000153	0.00141	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000151	0.0014	CcSEcCtD
Pilocarpine—Nausea—Capecitabine—esophageal cancer	0.000148	0.00136	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—esophageal cancer	0.000146	0.00135	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—esophageal cancer	0.000146	0.00135	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—esophageal cancer	0.000136	0.00126	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—esophageal cancer	0.000133	0.00123	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—esophageal cancer	0.000131	0.00121	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—esophageal cancer	0.000127	0.00117	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—esophageal cancer	0.000122	0.00113	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—esophageal cancer	0.000118	0.00109	CcSEcCtD
Pilocarpine—Rash—Methotrexate—esophageal cancer	0.000117	0.00108	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—esophageal cancer	0.000117	0.00108	CcSEcCtD
Pilocarpine—Headache—Methotrexate—esophageal cancer	0.000116	0.00107	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—esophageal cancer	0.00011	0.00101	CcSEcCtD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	4.54e-05	0.000492	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	4.52e-05	0.00049	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALOX15—esophageal cancer	4.52e-05	0.00049	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	4.5e-05	0.000488	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	4.5e-05	0.000488	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PLCE1—esophageal cancer	4.49e-05	0.000487	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ADH7—esophageal cancer	4.49e-05	0.000487	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—ANXA1—esophageal cancer	4.49e-05	0.000487	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—WIF1—esophageal cancer	4.47e-05	0.000485	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TYMP—esophageal cancer	4.47e-05	0.000485	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—WIF1—esophageal cancer	4.46e-05	0.000484	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	4.44e-05	0.000482	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—WIF1—esophageal cancer	4.41e-05	0.000479	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	4.4e-05	0.000477	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	4.38e-05	0.000476	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—SST—esophageal cancer	4.38e-05	0.000475	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—SST—esophageal cancer	4.37e-05	0.000474	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP26A1—esophageal cancer	4.35e-05	0.000471	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	4.34e-05	0.000471	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—SST—esophageal cancer	4.32e-05	0.000469	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—TPI1—esophageal cancer	4.31e-05	0.000467	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTO1—esophageal cancer	4.31e-05	0.000467	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	4.27e-05	0.000463	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	4.25e-05	0.000461	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALOX15—esophageal cancer	4.24e-05	0.000459	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	4.21e-05	0.000457	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALDOB—esophageal cancer	4.13e-05	0.000448	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	4.13e-05	0.000448	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	4.11e-05	0.000446	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	4.09e-05	0.000443	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	4.08e-05	0.000442	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	4.07e-05	0.000442	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TPI1—esophageal cancer	4.04e-05	0.000438	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTO1—esophageal cancer	4.04e-05	0.000438	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	4.04e-05	0.000438	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—SST—esophageal cancer	3.98e-05	0.000431	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.98e-05	0.000431	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—SST—esophageal cancer	3.96e-05	0.00043	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.94e-05	0.000427	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ADH1B—esophageal cancer	3.94e-05	0.000427	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—SST—esophageal cancer	3.93e-05	0.000426	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	3.91e-05	0.000425	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	3.9e-05	0.000423	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	3.88e-05	0.00042	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALDOB—esophageal cancer	3.87e-05	0.00042	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	3.86e-05	0.000419	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PFN1—esophageal cancer	3.86e-05	0.000419	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PFN1—esophageal cancer	3.85e-05	0.000417	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	3.83e-05	0.000415	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PFN1—esophageal cancer	3.81e-05	0.000413	CbGpPWpGaD
Pilocarpine—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	3.8e-05	0.000412	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	3.79e-05	0.000411	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TYMP—esophageal cancer	3.76e-05	0.000408	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GNG7—esophageal cancer	3.75e-05	0.000407	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GAPDH—esophageal cancer	3.73e-05	0.000404	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CRABP1—esophageal cancer	3.7e-05	0.000401	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP26A1—esophageal cancer	3.66e-05	0.000397	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALOX15—esophageal cancer	3.57e-05	0.000387	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GNG7—esophageal cancer	3.52e-05	0.000381	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALDH2—esophageal cancer	3.51e-05	0.000381	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	3.47e-05	0.000376	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	3.47e-05	0.000376	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	3.46e-05	0.000375	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	3.42e-05	0.000371	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TPI1—esophageal cancer	3.4e-05	0.000369	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTO1—esophageal cancer	3.4e-05	0.000369	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	3.4e-05	0.000368	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	3.39e-05	0.000368	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	3.39e-05	0.000367	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	3.38e-05	0.000366	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	3.35e-05	0.000363	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTT1—esophageal cancer	3.34e-05	0.000362	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALDH2—esophageal cancer	3.29e-05	0.000357	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALDOB—esophageal cancer	3.26e-05	0.000354	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GAPDH—esophageal cancer	3.14e-05	0.000341	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTT1—esophageal cancer	3.13e-05	0.00034	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS1—esophageal cancer	3.13e-05	0.00034	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ENO1—esophageal cancer	3.13e-05	0.00034	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	3.13e-05	0.000339	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	3.12e-05	0.000338	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CRABP1—esophageal cancer	3.11e-05	0.000338	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	3.1e-05	0.000336	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP2A6—esophageal cancer	3.1e-05	0.000336	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	3.09e-05	0.000335	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	3.09e-05	0.000335	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PSME1—esophageal cancer	3.08e-05	0.000335	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PSME2—esophageal cancer	3.08e-05	0.000335	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	3.06e-05	0.000332	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GNG7—esophageal cancer	2.96e-05	0.000321	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GNG7—esophageal cancer	2.95e-05	0.00032	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GNG7—esophageal cancer	2.94e-05	0.000319	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ENO1—esophageal cancer	2.94e-05	0.000318	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS1—esophageal cancer	2.94e-05	0.000318	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GNG7—esophageal cancer	2.91e-05	0.000316	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PSME2—esophageal cancer	2.89e-05	0.000314	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PSME1—esophageal cancer	2.89e-05	0.000314	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.88e-05	0.000313	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.88e-05	0.000313	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.78e-05	0.000301	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—XIAP—esophageal cancer	2.76e-05	0.0003	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—XIAP—esophageal cancer	2.75e-05	0.000299	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—XIAP—esophageal cancer	2.73e-05	0.000296	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.66e-05	0.000289	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.64e-05	0.000286	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	2.61e-05	0.000283	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.61e-05	0.000283	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	2.6e-05	0.000283	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	2.6e-05	0.000282	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	2.59e-05	0.000281	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	2.58e-05	0.00028	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	2.56e-05	0.000278	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	2.5e-05	0.000271	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP1B1—esophageal cancer	2.5e-05	0.000271	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.47e-05	0.000268	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ENO1—esophageal cancer	2.47e-05	0.000268	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.45e-05	0.000266	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CA1—esophageal cancer	2.45e-05	0.000266	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PSME2—esophageal cancer	2.44e-05	0.000264	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PSME1—esophageal cancer	2.44e-05	0.000264	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PSME2—esophageal cancer	2.43e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PSME1—esophageal cancer	2.43e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PSME2—esophageal cancer	2.42e-05	0.000262	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PSME1—esophageal cancer	2.42e-05	0.000262	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	2.42e-05	0.000262	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	2.41e-05	0.000261	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PSME1—esophageal cancer	2.4e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PSME2—esophageal cancer	2.4e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	2.38e-05	0.000259	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SST—esophageal cancer	2.35e-05	0.000255	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP19A1—esophageal cancer	2.35e-05	0.000255	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SST—esophageal cancer	2.34e-05	0.000254	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SST—esophageal cancer	2.32e-05	0.000252	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	2.29e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GHRL—esophageal cancer	2.29e-05	0.000248	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HMOX1—esophageal cancer	2.28e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GHRL—esophageal cancer	2.28e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	2.28e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	2.26e-05	0.000245	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	2.26e-05	0.000245	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	2.25e-05	0.000244	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	2.25e-05	0.000244	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CA2—esophageal cancer	2.24e-05	0.000243	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	2.22e-05	0.000241	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ABCB1—esophageal cancer	2.19e-05	0.000238	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HMOX1—esophageal cancer	2.14e-05	0.000232	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	2.1e-05	0.000228	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.08e-05	0.000226	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADH7—esophageal cancer	2.08e-05	0.000226	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ABCB1—esophageal cancer	2.06e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	2.05e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	2.05e-05	0.000222	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	2.03e-05	0.00022	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.98e-05	0.000215	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.83e-05	0.000198	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	1.82e-05	0.000198	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	1.82e-05	0.000197	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.8e-05	0.000196	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	1.8e-05	0.000195	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.75e-05	0.000189	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.73e-05	0.000188	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	1.72e-05	0.000187	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	1.72e-05	0.000186	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	1.7e-05	0.000185	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.7e-05	0.000184	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.66e-05	0.00018	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.58e-05	0.000171	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.58e-05	0.000171	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.51e-05	0.000164	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.46e-05	0.000159	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.46e-05	0.000158	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.44e-05	0.000157	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	1.41e-05	0.000153	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	1.41e-05	0.000153	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	1.39e-05	0.000151	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.37e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—esophageal cancer	1.35e-05	0.000146	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—esophageal cancer	1.35e-05	0.000146	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—esophageal cancer	1.33e-05	0.000144	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NOS3—esophageal cancer	1.31e-05	0.000142	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.29e-05	0.00014	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	1.27e-05	0.000138	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	1.27e-05	0.000137	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	1.25e-05	0.000136	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NOS3—esophageal cancer	1.23e-05	0.000133	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.22e-05	0.000133	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.21e-05	0.000131	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.00013	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.16e-05	0.000126	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	1.15e-05	0.000125	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	1.15e-05	0.000125	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.15e-05	0.000124	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.15e-05	0.000124	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	1.14e-05	0.000123	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	1.13e-05	0.000123	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.13e-05	0.000123	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.13e-05	0.000123	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	1.13e-05	0.000122	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—esophageal cancer	1.13e-05	0.000122	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	1.12e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.08e-05	0.000117	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	1.08e-05	0.000117	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.07e-05	0.000116	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NOS3—esophageal cancer	1.04e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	1.03e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	1.03e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	1.02e-05	0.00011	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—esophageal cancer	9.98e-06	0.000108	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	9.83e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	9.8e-06	0.000106	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.76e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	9.7e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	9.65e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	9.62e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	9.53e-06	0.000103	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—esophageal cancer	9.48e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—esophageal cancer	9.36e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.17e-06	9.95e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	8.53e-06	9.25e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	8.5e-06	9.22e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	8.42e-06	9.13e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.37e-06	9.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	8.25e-06	8.95e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	8.22e-06	8.92e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	8.14e-06	8.83e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.04e-06	8.72e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—esophageal cancer	7.88e-06	8.55e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—esophageal cancer	7.85e-06	8.51e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—esophageal cancer	7.82e-06	8.49e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—esophageal cancer	7.75e-06	8.4e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	7.38e-06	8.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—esophageal cancer	6.92e-06	7.51e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—esophageal cancer	6.84e-06	7.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—esophageal cancer	6.82e-06	7.4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—esophageal cancer	6.75e-06	7.32e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	6.69e-06	7.26e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	6.67e-06	7.23e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	6.6e-06	7.16e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.83e-06	6.33e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.81e-06	6.3e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	5.79e-06	6.28e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	5.73e-06	6.22e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—esophageal cancer	5.62e-06	6.09e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—esophageal cancer	5.6e-06	6.07e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—esophageal cancer	5.54e-06	6.01e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.37e-06	5.83e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.81e-06	5.22e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.4e-06	4.77e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—esophageal cancer	3.66e-06	3.97e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.71e-06	2.94e-05	CbGpPWpGaD
